Development status of miltefosine as first oral drug in visceral and cutaneous leishmaniasis.
Pearson
Richard D.
RD
Box 485, Division of Geographic and International Medicine, Department of Medicine, University of Virginia Health System, Charlottesville, VA 22908, USA.